Vytrus Biotech, S.A. (BME:VYT)
Spain flag Spain · Delayed Price · Currency is EUR
13.15
-0.05 (-0.38%)
Last updated: Nov 13, 2026, 1:21 PM CET

Vytrus Biotech Statistics

Total Valuation

Vytrus Biotech has a market cap or net worth of EUR 98.94 million. The enterprise value is 95.98 million.

Market Cap98.94M
Enterprise Value 95.98M

Important Dates

The next estimated earnings date is Thursday, March 25, 2027.

Earnings Date Mar 25, 2027
Ex-Dividend Date n/a

Share Statistics

Vytrus Biotech has 7.52 million shares outstanding.

Current Share Class 7.52M
Shares Outstanding 7.52M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 33.90%
Owned by Institutions (%) 15.24%
Float 3.77M

Valuation Ratios

The trailing PE ratio is 24.53 and the forward PE ratio is 23.88.

PE Ratio 24.53
Forward PE 23.88
PS Ratio 9.90
PB Ratio 7.61
P/TBV Ratio 13.03
P/FCF Ratio 33.22
P/OCF Ratio 20.93
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.93, with an EV/FCF ratio of 32.22.

EV / Earnings 23.80
EV / Sales 9.60
EV / EBITDA 19.93
EV / EBIT 21.17
EV / FCF 32.22

Financial Position

The company has a current ratio of 3.42, with a Debt / Equity ratio of 0.08.

Current Ratio 3.42
Quick Ratio 3.09
Debt / Equity 0.08
Debt / EBITDA 0.20
Debt / FCF 0.33
Interest Coverage 60.39

Financial Efficiency

Return on equity (ROE) is 36.82% and return on invested capital (ROIC) is 40.37%.

Return on Equity (ROE) 36.82%
Return on Assets (ROA) 18.44%
Return on Invested Capital (ROIC) 40.37%
Return on Capital Employed (ROCE) 28.93%
Weighted Average Cost of Capital (WACC) 3.91%
Revenue Per Employee 212,702
Profits Per Employee 85,806
Employee Count47
Asset Turnover 0.65
Inventory Turnover 1.58

Taxes

In the past 12 months, Vytrus Biotech has paid 476,768 in taxes.

Income Tax 476,768
Effective Tax Rate 10.57%

Stock Price Statistics

The stock price has increased by +64.38% in the last 52 weeks. The beta is -0.07, so Vytrus Biotech's price volatility has been lower than the market average.

Beta (5Y) -0.07
52-Week Price Change +64.38%
50-Day Moving Average 15.34
200-Day Moving Average 15.98
Relative Strength Index (RSI) 52.21
Average Volume (20 Days) 4,434

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Vytrus Biotech had revenue of EUR 10.00 million and earned 4.03 million in profits. Earnings per share was 0.54.

Revenue10.00M
Gross Profit 9.10M
Operating Income 4.53M
Pretax Income 4.51M
Net Income 4.03M
EBITDA 4.82M
EBIT 4.53M
Earnings Per Share (EPS) 0.54
Full Income Statement

Balance Sheet

The company has 3.95 million in cash and 987,122 in debt, with a net cash position of 2.96 million or 0.39 per share.

Cash & Cash Equivalents 3.95M
Total Debt 987,122
Net Cash 2.96M
Net Cash Per Share 0.39
Equity (Book Value) 13.00M
Book Value Per Share 1.73
Working Capital 4.59M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.73 million and capital expenditures -1.75 million, giving a free cash flow of 2.98 million.

Operating Cash Flow 4.73M
Capital Expenditures -1.75M
Depreciation & Amortization 281,992
Net Borrowing -596,773
Free Cash Flow 2.98M
FCF Per Share 0.40
Full Cash Flow Statement

Margins

Gross margin is 91.06%, with operating and profit margins of 45.35% and 40.34%.

Gross Margin 91.06%
Operating Margin 45.35%
Pretax Margin 45.11%
Profit Margin 40.34%
EBITDA Margin 48.17%
EBIT Margin 45.35%
FCF Margin 29.80%

Dividends & Yields

Vytrus Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 4.08%
FCF Yield 3.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Vytrus Biotech has an Altman Z-Score of 12.69 and a Piotroski F-Score of 8.

Altman Z-Score 12.69
Piotroski F-Score 8